Eurocine Vaccines AB   Report issue

For profit Phase 2
Founded: Solna Sweden (1999)
Status: Left NME R&D (2023)

Organization Overview

First Clinical Trial
2011
NCT01473810
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Eurocine Vaccines AB

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

HIV Infections (Phase 2)

Influenza, Human (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 6